SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-24-009973
Filing Date
2024-02-02
Accepted
2024-02-01 20:55:44
Documents
13
Period of Report
2024-01-30
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A crbp-20240130.htm   iXBRL 8-K/A 47067
2 EX-5.1 crbp-ex5_1.htm EX-5.1 19203
  Complete submission text file 0000950170-24-009973.txt   187679

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crbp-20240130.xsd EX-101.SCH 25955
15 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20240130_htm.xml XML 5431
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37348 | Film No.: 24588576
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)